DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
Minutes of Meeting 1 
February 10-11, 1992 
The Recombinant DNA Advisory Committee (RAC) was convened for its forty-eighth 
meeting at 9:00 a.m. on February 10, 1992, in Building 3 1C, Conference Room 10, 
National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. 
Barbara E. Murray (Chair) presided. In accordance with Public Law 92-463, the meeting 
was open to the public. The following were present for all or part of the meeting: 
Committee Members: 
John H. Barton, Stanford Law School 
Constance E. Brinckerhoff, Dartmouth Medical School 
Nancy L. Buc, Weil, Gotshal and Manges 
Ira H. Carmen, University of Illinois 
Roy H. Doi, University of California, Davis 
E. Peter Geiduschek, University of California, San Diego 
Martin F. Gellert, National Institutes of Health 
Robert Haselkom, University of Chicago 
Susan S. Hirano, University of Wisconsin 
William N. Kelley, University of Pennsylvania Medical Center 
Donald J. Krogstad, Washington University School of Medicine 
Brigid G. Leventhal, Johns Hopkins University School of Medicine 
Brian F. Mannix, Buckland Mill Associates 
R. Scott Mclvor, University of Minnesota 
Barbara E. Murray, University of Texas, Houston 
Robert F. Murray, Howard University 
Leonard E. Post, Parke-Davis Pharmaceutical Division 
Executive Secretary: 
Nelson A. Wivel, National Institutes of Health 
A committee roster is attached (Attachment). 
hh e RAC is advisory to the National Institutes of Health (NIH), and its recommendations should not be considered as final or 
accepted. The Office of Recombinant DNA Activities should be consulted for NIH policy on specific issues. 
[312] 
Recombinant DNA Research, Volume 15 
